Tapewire

Nasdaq · USD

ANIP

ANI PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
4638
SEC CIK
0001023024
Parsed reports
463

Last 12 months

Inside the activity.

0 purchase rows · 48 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202503
Jan 202601
Feb 202605
Mar 2026012
Apr 202601
May 202606
Jun 202604
Jul 202603
Aug 202604
Sep 202604
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 18, 2025 Filed Dec 19, 2025 21:47 UTC
Davis KristaSVP, CHIEF HR OFFICER
SaleCommon Stock 1,622 $82.40 $133,652.80
Disclosure

SEC source: 0001946439-25-000019 · wk-form4_1766180822.xml · nonDerivative · entry 1

Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,564

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025.

Read SEC document
December 12, 2025 Filed Dec 12, 2025 21:26 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 400 $82.32 $32,928.00
Disclosure

SEC source: 0001938861-25-000030 · wk-form4_1765574758.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,874

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 23:09 UTC SaleCommon Stock 1,800 $81.15 $146,070.00
Disclosure

SEC source: 0001543174-25-000006 · wk-form4_1765321783.xml · nonDerivative · entry 1

TANNENBAUM RENEE P · CIK 0001543174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,157

F1 · price: The shares were sold in multiple trades at prices ranging from $81.14 to $81.16. The price reported above reflects the weighted average sales price.

Read SEC document
November 13, 2025 Filed Nov 14, 2025 21:30 UTC
Gassert ChadSVP - CORP. DEV. & STRATEGY
SaleCommon Stock 94 $88.00 $8,272.00
Disclosure

SEC source: 0001871002-25-000007 · wk-form4_1763155816.xml · nonDerivative · entry 3

Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Chali Properties LLC

Disclosed balance after: 158,490

F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.

Read SEC document
November 13, 2025 Filed Nov 14, 2025 21:26 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 400 $87.27 $34,908.00
Disclosure

SEC source: 0001938861-25-000028 · wk-form4_1763155617.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,274

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 23:01 UTC GiftCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001720568-25-000007 · wk-form4_1763420495.xml · nonDerivative · entry 2

Walsh Patrick D · CIK 0001720568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,405

F2 · kind: This transaction reported on this Form 4 reflects a bona fide gift of Company's common stock to a donor-advised fund ("DAF") for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution.

Read SEC document
November 13, 2025 Filed Nov 17, 2025 23:01 UTC SaleCommon Stock 8,643 $86.88 $750,903.84
Disclosure

SEC source: 0001720568-25-000007 · wk-form4_1763420495.xml · nonDerivative · entry 1

Walsh Patrick D · CIK 0001720568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,405

F1 · price: The shares were sold in multiple trades at prices ranging from $86.15 to $87.80. The price reported above reflects the weighted average sales price.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 21:30 UTC
Gassert ChadSVP - CORP. DEV. & STRATEGY
SaleCommon Stock 14,642 $89.07 $1,304,162.94
Disclosure

SEC source: 0001871002-25-000007 · wk-form4_1763155816.xml · nonDerivative · entry 2

Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Chali Properties LLC

Disclosed balance after: 158,584

F1 · price: The shares were sold in multiple trades at prices ranging from $89.00 to $89.50. The price reported above reflects the weighted average sales price.

F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.

Read SEC document
October 13, 2025 Filed Oct 14, 2025 23:49 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 400 $90.09 $36,036.00
Disclosure

SEC source: 0001938861-25-000026 · wk-form4_1760485793.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,674

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.

Read SEC document
September 19, 2025 Filed Sep 22, 2025 21:14 UTC
Davis KristaSVP, CHIEF HR OFFICER
SaleCommon Stock 1,000 $98.04 $98,040.00
Disclosure

SEC source: 0001946439-25-000017 · wk-form4_1758575697.xml · nonDerivative · entry 1

Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,186

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 23:17 UTC
Davis KristaSVP, CHIEF HR OFFICER
Tax withholdingCommon Stock 1,710 $97.71 $167,084.10
Disclosure

SEC source: 0001946439-25-000015 · wk-form4_1757978243.xml · nonDerivative · entry 1

Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,186

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,108 shares of restricted stock, the grant of which was previously reported.

Read SEC document
September 12, 2025 Filed Sep 15, 2025 23:16 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 400 $98.42 $39,368.00
Disclosure

SEC source: 0001938861-25-000024 · wk-form4_1757978190.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,074

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.

Read SEC document
September 03, 2025 Filed Sep 4, 2025 20:44 UTC SaleCommon Stock 7,292 $94.94 $692,302.48
Disclosure

SEC source: 0001689325-25-000008 · wk-form4_1757018695.xml · nonDerivative · entry 1

Pera Antonio R · CIK 0001689325 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,660

Read SEC document
August 25, 2025 Filed Aug 26, 2025 22:19 UTC SaleCommon Stock 2,528 $90.62 $229,087.36
Disclosure

SEC source: 0001773152-25-000007 · wk-form4_1756246788.xml · nonDerivative · entry 1

Leonard Matthew J · CIK 0001773152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,864

Read SEC document
August 22, 2025 Filed Aug 25, 2025 20:19 UTC
Davis KristaSVP, CHIEF HR OFFICER
SaleCommon Stock 1,763 $91.10 $160,609.30
Disclosure

SEC source: 0001946439-25-000013 · wk-form4_1756153167.xml · nonDerivative · entry 1

Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,896

F1 · price: The shares were sold in multiple trades at prices ranging from $91.01 to $91.19. The price reported above reflects the weighted average sales price.

Read SEC document
August 21, 2025 Filed Aug 22, 2025 22:10 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 52,988 $90.44 $4,792,234.72
Disclosure

SEC source: 0001870913-25-000008 · wk-form4_1755900596.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 431,920

F3 · price: The shares were sold in multiple trades at prices ranging from $89.90 to $91.44. The price reported above reflects the weighted average sales price.

F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
August 20, 2025 Filed Aug 20, 2025 20:41 UTC SaleCommon Stock 5,421 $89.73 $486,426.33
Disclosure

SEC source: 0001689325-25-000005 · wk-form4_1755722489.xml · nonDerivative · entry 1

Pera Antonio R · CIK 0001689325 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,952

F1 · price: The shares were sold in multiple trades at prices ranging from $89.27 to $90.18. The price reported above reflects the weighted average sales price.

Read SEC document
August 20, 2025 Filed Aug 22, 2025 22:10 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 47,012 $90.27 $4,243,773.24
Disclosure

SEC source: 0001870913-25-000008 · wk-form4_1755900596.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 484,908

F1 · price: The shares were sold in multiple trades at prices ranging from $89.21 to $90.83. The price reported above reflects the weighted average sales price.

F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
August 18, 2025 Filed Aug 18, 2025 21:23 UTC SaleCommon Stock 6,937 $88.17 $611,635.29
Disclosure

SEC source: 0001773152-25-000004 · wk-form4_1755552234.xml · nonDerivative · entry 1

Leonard Matthew J · CIK 0001773152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,392

F1 · price: The shares were sold in multiple trades at prices ranging from $87.66 to $88.36. The price reported above reflects the weighted average sales price.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:42 UTC
Thoma JeanneDirector
SaleCommon Stock 14,675 $88.87 $1,304,167.25
Disclosure

SEC source: 0001819879-25-000004 · wk-form4_1755722518.xml · nonDerivative · entry 2

Thoma Jeanne · CIK 0001819879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,405

F2 · price: The shares were sold in multiple trades at prices ranging from $88.74 to $89.39. The price reported above reflects the weighted average sales price.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 20:42 UTC
Thoma JeanneDirector
SaleCommon Stock 6,865 $89.76 $616,202.40
Disclosure

SEC source: 0001819879-25-000004 · wk-form4_1755722518.xml · nonDerivative · entry 1

Thoma Jeanne · CIK 0001819879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,080

F1 · price: The shares were sold in multiple trades at prices ranging from $89.75 to $89.90. The price reported above reflects the weighted average sales price.

Read SEC document
August 15, 2025 Filed Aug 18, 2025 20:34 UTC SaleCommon Stock 9,000 $89.05 $801,450.00
Disclosure

SEC source: 0001720568-25-000004 · wk-form4_1755549267.xml · nonDerivative · entry 1

Walsh Patrick D · CIK 0001720568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,048

Read SEC document
August 15, 2025 Filed Aug 18, 2025 20:32 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 52,990 $87.15 $4,618,078.50
Disclosure

SEC source: 0001870913-25-000006 · wk-form4_1755549120.xml · nonDerivative · entry 3

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 531,920

F3 · price: The shares were sold in multiple trades at prices ranging from $85.44 to $90.00. The price reported above reflects the weighted average sales price.

F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
August 15, 2025 Filed Aug 18, 2025 20:29 UTC
Gassert ChadSVP - CORP. DEV. & STRATEGY
SaleCommon Stock 20,000 $86.97 $1,739,400.00
Disclosure

SEC source: 0001871002-25-000004 · wk-form4_1755548946.xml · nonDerivative · entry 2

Gassert Chad · CIK 0001871002 · SVP - CORP. DEV. & STRATEGY

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Chali Properties LLC

Disclosed balance after: 173,226

F1 · price: The shares were sold in multiple trades at prices ranging from $86.54 to $88.05. The price reported above reflects the weighted average sales price.

F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.

Read SEC document
August 14, 2025 Filed Aug 18, 2025 20:32 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 47,010 $89.48 $4,206,454.80
Disclosure

SEC source: 0001870913-25-000006 · wk-form4_1755549120.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 584,910

F1 · price: The shares were sold in multiple trades at prices ranging from $88.20 to $90.11. The price reported above reflects the weighted average sales price.

F2 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
August 13, 2025 Filed Aug 14, 2025 21:43 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 400 $88.87 $35,548.00
Disclosure

SEC source: 0001938861-25-000020 · wk-form4_1755207827.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,474

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 21:53 UTC
Rowland Thomas AndrewSVP, HEAD - ESTABLISHED BRANDS
SaleCommon Stock 4,975 $85.71 $426,407.25
Disclosure

SEC source: 0001507496-25-000007 · wk-form4_1755208382.xml · nonDerivative · entry 1

Rowland Thomas Andrew · CIK 0001507496 · SVP, HEAD - ESTABLISHED BRANDS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,794

F1 · shares: The shares were sold in multiple trades at prices ranging from $85.52 to $86.22. The price reported above reflects the weighted average sales price.

F2 · balance_after: Includes 304 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
August 12, 2025 Filed Aug 14, 2025 21:48 UTC
Lalwani NikhilDirector · PRESIDENT & CEO
SaleCommon Stock 56,960 $85.93 $4,894,572.80
Disclosure

SEC source: 0001822629-25-000010 · wk-form4_1755208123.xml · nonDerivative · entry 1

Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 411,219

F1 · price: The shares were sold in multiple trades at prices ranging from $84.40 to $87.47. The price reported above reflects the weighted average sales price.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 21:46 UTC
Gutwerg OriSVP, GENERICS
SaleCommon Stock 5,873 $86.53 $508,190.69
Disclosure

SEC source: 0001846478-25-000013 · wk-form4_1755207996.xml · nonDerivative · entry 1

Gutwerg Ori · CIK 0001846478 · SVP, GENERICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,024

F1 · price: The shares were sold in multiple trades at prices ranging from $86.50 to $86.79. The price reported above reflects the weighted average sales price.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 21:40 UTC Exercise / conversionStock Option (right to buy) · Derivative 50,000 $46.49 Strike: $46.49 $2,324,500.00
Disclosure

SEC source: 0001674236-25-000010 · wk-form4_1755207652.xml · derivative · entry 3

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 50,000 shares

Expires 2026-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 25% of the total options vested on each of May 6, 2017, May 6, 2018, May 6, 2019, and May 6, 2020.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 21:40 UTC SaleCommon Stock 50,000 $86.07 $4,303,500.00
Disclosure

SEC source: 0001674236-25-000010 · wk-form4_1755207652.xml · nonDerivative · entry 2

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,863

Read SEC document
August 12, 2025 Filed Aug 14, 2025 21:40 UTC Exercise / conversionCommon Stock 50,000 $46.49 $2,324,500.00
Disclosure

SEC source: 0001674236-25-000010 · wk-form4_1755207652.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 21:38 UTC SaleCommon Stock 19,341 $85.93 $1,661,972.13
Disclosure

SEC source: 0001272247-25-000005 · wk-form4_1755207514.xml · nonDerivative · entry 1

HAUGHEY THOMAS · CIK 0001272247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,521

F1 · price: The shares were sold in multiple trades at prices ranging from $84.50 to $87.16. The price reported above reflects the weighted average sales price.

Read SEC document
July 18, 2025 Filed Jul 21, 2025 20:12 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
Tax withholdingCommon Stock 2,071 $66.30 $137,307.30
Disclosure

SEC source: 0001938861-25-000018 · wk-form4_1753128770.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,874

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported.

Read SEC document
July 14, 2025 Filed Jul 14, 2025 20:11 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 400 $64.88 $25,952.00
Disclosure

SEC source: 0001938861-25-000016 · wk-form4_1752523859.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 78,945

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 21:24 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 400 $61.37 $24,548.00
Disclosure

SEC source: 0001938861-25-000014 · wk-form4_1750109077.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,345

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.

Read SEC document
May 22, 2025 Filed May 27, 2025 22:21 UTC GrantCommon Stock 4,336 $0.00 $0.00
Disclosure

SEC source: 0001272247-25-000003 · wk-form4_1748384492.xml · nonDerivative · entry 1

HAUGHEY THOMAS · CIK 0001272247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,862

F1 · kind: Represents a restricted stock award that will vest in full on May 22, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 22:19 UTC GrantCommon Stock 4,336 $0.00 $0.00
Disclosure

SEC source: 0001773152-25-000002 · wk-form4_1748384342.xml · nonDerivative · entry 1

Leonard Matthew J · CIK 0001773152 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,329

F1 · kind: Represents a restricted stock award that will vest in full on May 22, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 22:18 UTC GrantCommon Stock 4,336 $0.00 $0.00
Disclosure

SEC source: 0001689325-25-000002 · wk-form4_1748384278.xml · nonDerivative · entry 1

Pera Antonio R · CIK 0001689325 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,373

F1 · kind: Represents a restricted stock award that will vest in full on May 22, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 22:16 UTC
Thoma JeanneDirector
GrantCommon Stock 4,336 $0.00 $0.00
Disclosure

SEC source: 0001819879-25-000002 · wk-form4_1748384174.xml · nonDerivative · entry 1

Thoma Jeanne · CIK 0001819879 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,945

F1 · kind: Represents a restricted stock award that will vest in full on May 22, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 22:17 UTC GrantCommon Stock 4,336 $0.00 $0.00
Disclosure

SEC source: 0001543174-25-000002 · wk-form4_1748384233.xml · nonDerivative · entry 1

TANNENBAUM RENEE P · CIK 0001543174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,957

F1 · kind: Represents a restricted stock award that will vest in full on May 22, 2026.

Read SEC document
May 22, 2025 Filed May 27, 2025 22:15 UTC GrantCommon Stock 4,336 $0.00 $0.00
Disclosure

SEC source: 0001720568-25-000002 · wk-form4_1748384127.xml · nonDerivative · entry 1

Walsh Patrick D · CIK 0001720568 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,048

F1 · kind: Represents a restricted stock award that will vest in full on May 22, 2026.

Read SEC document
May 15, 2025 Filed May 16, 2025 20:57 UTC
Gutwerg OriSVP, GENERICS
SaleCommon Stock 881 $60.07 $52,921.67
Disclosure

SEC source: 0001846478-25-000011 · wk-form4_1747429059.xml · nonDerivative · entry 1

Gutwerg Ori · CIK 0001846478 · SVP, GENERICS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,897

F1 · price: The shares were sold in multiple trades at prices ranging from $60.06 to $60.09. The price reported above reflects the weighted average sales price.

Read SEC document
May 14, 2025 Filed May 16, 2025 00:10 UTC
Mutz ChristopherHEAD OF RARE DISEASE
SaleCommon Stock 4,000 $60.45 $241,800.00
Disclosure

SEC source: 0001846487-25-000008 · wk-form4_1747354237.xml · nonDerivative · entry 1

Mutz Christopher · CIK 0001846487 · HEAD OF RARE DISEASE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,317

Read SEC document
May 13, 2025 Filed May 13, 2025 20:29 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 400 $62.20 $24,880.00
Disclosure

SEC source: 0001938861-25-000012 · wk-form4_1747168179.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 79,745

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.

Read SEC document
May 09, 2025 Filed May 13, 2025 20:21 UTC
Shanmugam MuthusamyDirector · HEAD OF R&D, COO-NOVITIUM OPS
SaleCommon Stock 700 $76.83 $53,781.00
Disclosure

SEC source: 0001870913-25-000004 · wk-form4_1747167705.xml · nonDerivative · entry 2

Shanmugam Muthusamy · CIK 0001870913 · Director · HEAD OF R&D, COO-NOVITIUM OPS

10b5-1 filing: Plan reported

Ownership: Indirect · Held by Esjay LLC

Disclosed balance after: 631,920

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2024.

F2 · price: The shares were sold in multiple trades at prices ranging from $76.11 to $76.95. The price reported above reflects the weighted average sales price.

F3 · ownership.nature: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.

Read SEC document
April 14, 2025 Filed Apr 14, 2025 20:17 UTC
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
SaleCommon Stock 400 $68.96 $27,584.00
Disclosure

SEC source: 0001938861-25-000010 · wk-form4_1744661821.xml · nonDerivative · entry 1

Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,145

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.

Read SEC document
March 23, 2025 Filed Mar 25, 2025 20:44 UTC Tax withholdingCommon Stock 6,210 $64.26 $399,054.60
Disclosure

SEC source: 0001674236-25-000008 · wk-form4_1742935483.xml · nonDerivative · entry 1

CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,863

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,618 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 23, 2025 Filed Mar 25, 2025 20:47 UTC
Lalwani NikhilDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 17,455 $64.26 $1,121,658.30
Disclosure

SEC source: 0001822629-25-000008 · wk-form4_1742935660.xml · nonDerivative · entry 1

Lalwani Nikhil · CIK 0001822629 · Director · PRESIDENT & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 468,179

F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 34,124 shares of restricted stock, the grant of which was previously reported.

Read SEC document
March 19, 2025 Filed Mar 20, 2025 20:14 UTC
Davis KristaSVP, CHIEF HR OFFICER
SaleCommon Stock 1,866 $65.00 $121,290.00
Disclosure

SEC source: 0001946439-25-000010 · wk-form4_1742501635.xml · nonDerivative · entry 1

Davis Krista · CIK 0001946439 · SVP, CHIEF HR OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,659

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.